首页> 外文期刊>癌症生物学与医学(英文版 ) >Analysis of the HNF4A isoform-regulated transcriptome identifies CCL15 as a downstream target in gastric carcinogenesis
【24h】

Analysis of the HNF4A isoform-regulated transcriptome identifies CCL15 as a downstream target in gastric carcinogenesis

机译:Analysis of the HNF4A isoform-regulated transcriptome identifies CCL15 as a downstream target in gastric carcinogenesis

获取原文
获取原文并翻译 | 示例
       

摘要

Objective:Hepatocyte nuclear factor 4α(HNF4 A)has been demonstrated to be an oncogene in gastric cancer(GC).However,the roles of different HNF4 A isoforms derived from the 2 different promoters(P1 and P2)and the underlying mechanisms remain obscure.Methods:The expression and prognostic values of P1-and P2-HNF4 A were evaluated in The Cancer Genome Atlas(TCGA)databases and GC tissues.Then,functional assays of P1-and P2-HNF4 A were conducted both in vivo and in vitro.High-throughput RNA-seq was employed to profile downstream pathways in P1-and P2-HNF4 A-overexpressing GC cells.The expression and gene regulation network of the candidate target genes identified by RNA-seq were characterized based on data mining and functional assays.Results:HNF4 A amplification was a key characteristic of GC in TCGA databases,especially for the intestinal type and early stage.Moreover,P1-HNF4 A expression was significantly higher in tumor tissues than in adjacent non-tumor tissues(P0.05).High P1-HNF4 A expression indicated poor prognoses in GC patients(P<0.01).Furthermore,P1-HNF4 A overexpression significantly promoted SGC7901 and BGC823 cell proliferation,invasion and migration in vitro(P<0.01).Murine xenograft experiments showed that P1-HNF4 A overexpression promoted tumor growth(P<0.05).Mechanistically,RNA-seq showed that the cytokine-cytokine receptor interactions pathway was mostly enriched in P1-HNF4 A-overexpressing GC cells.Finally,chemokine(C-C motif)ligand 15 was identified as a direct target of P1-HNF4 A in GC tissues.Conclusions:P1-HNF4 A was the main oncogene during GC progression.The cytokine-cytokine receptor interaction pathway played a pivotal role and may be a promising therapeutic target.

著录项

  • 来源
    《癌症生物学与医学(英文版 )》 |2021年第2期|530-546|共17页
  • 作者单位

    State Key Laboratory of Cancer Biology & Institute of Digestive Diseases Xijing Hospital Air Force Medical University of PLA Xi'an 710032 China;

    Department of Gastroenterology General Hospital of Western Theater Command Chengdu 610083 China;

    Department of Gastroenterology First Affiliated Hospital of Zhengzhou University Zhengzhou 450052 China;

    Department of Endocrinology General Hospital of Western Theater Command Chengdu 610083 China;

    Department of Endocrinology General Hospital of Western Theater Command Chengdu 610083 China;

    Department of Gastroenterology 989 Hospital of the People's Liberation Army Luoyang 471003 China;

    Department of Gastroenterology First Affiliated Hospital of Xi'an Medical College Xi'an 710038 China;

    State Key Laboratory of Cancer Biology & Institute of Digestive Diseases Xijing Hospital Air Force Medical University of PLA Xi'an 710032 China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-19 05:01:14
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号